JP2025500971A5 - - Google Patents
Info
- Publication number
- JP2025500971A5 JP2025500971A5 JP2024538031A JP2024538031A JP2025500971A5 JP 2025500971 A5 JP2025500971 A5 JP 2025500971A5 JP 2024538031 A JP2024538031 A JP 2024538031A JP 2024538031 A JP2024538031 A JP 2024538031A JP 2025500971 A5 JP2025500971 A5 JP 2025500971A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021141294 | 2021-12-24 | ||
| CNPCT/CN2021/141294 | 2021-12-24 | ||
| CNPCT/CN2022/134293 | 2022-11-25 | ||
| CN2022134293 | 2022-11-25 | ||
| PCT/CN2022/141670 WO2023116925A1 (en) | 2021-12-24 | 2022-12-23 | Novel anti-tslp antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025500971A JP2025500971A (ja) | 2025-01-15 |
| JP2025500971A5 true JP2025500971A5 (https=) | 2026-01-06 |
Family
ID=86901374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538031A Pending JP2025500971A (ja) | 2021-12-24 | 2022-12-23 | 新規の抗ｔｓｌｐ抗体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250051433A1 (https=) |
| EP (1) | EP4453030A1 (https=) |
| JP (1) | JP2025500971A (https=) |
| KR (1) | KR20240128709A (https=) |
| CN (1) | CN118475607A (https=) |
| AU (1) | AU2022423383A1 (https=) |
| CA (1) | CA3244178A1 (https=) |
| IL (1) | IL313679A (https=) |
| MX (1) | MX2024007966A (https=) |
| TW (1) | TW202337898A (https=) |
| WO (1) | WO2023116925A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202448501A (zh) | 2023-02-02 | 2024-12-16 | 美商麥迪紐有限責任公司 | 用抗ｔｓｌｐ抗體治療慢性鼻竇炎 |
| IL324470A (en) | 2023-05-18 | 2026-01-01 | Medimmune Llc | Treatment of corticosteroid-dependent asthma using anti-TSLP antibody |
| AR134102A1 (es) * | 2023-10-12 | 2025-12-03 | Innovent Biologics Suzhou Co Ltd | ANTICUERPOS ANTI-IL-4Ra Y USOS DE LOS MISMOS |
| WO2025108394A1 (zh) * | 2023-11-22 | 2025-05-30 | 联邦生物科技(珠海横琴)有限公司 | 抗IL-4Rα抗体或其抗原结合片段及其双特异性抗体和应用 |
| WO2025108344A1 (zh) * | 2023-11-22 | 2025-05-30 | 上海华奥泰生物药业股份有限公司 | 靶向tslp的抗原结合蛋白及应用 |
| CN119735676B (zh) * | 2023-12-26 | 2025-12-16 | 华润生物医药有限公司 | 抗tslp抗体及其用途 |
| WO2025147632A1 (en) | 2024-01-05 | 2025-07-10 | Medimmune, Llc | Treatment of chronic obstructive pulmonary disease with anti-tslp antibody |
| TW202529811A (zh) | 2024-01-29 | 2025-08-01 | 瑞典商阿斯特捷利康公司 | 胸腺基質淋巴細胞生成素（ｔｓｌｐ）結合片段之組成物及其使用方法 |
| WO2025195445A1 (zh) * | 2024-03-21 | 2025-09-25 | 北京三诺佳邑生物技术有限责任公司 | 特异性结合light和tslp的多特异性抗体以及组合物及其应用 |
| WO2025221247A1 (en) | 2024-04-17 | 2025-10-23 | Amgen Inc. | Treatment of eosinophilic esophagitis with anti-tslp antibody |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7982016B2 (en) * | 2007-09-10 | 2011-07-19 | Amgen Inc. | Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| HRP20210650T1 (hr) * | 2015-09-09 | 2021-05-28 | Novartis Ag | Protutijela koja vežu timusni stromalni limfopoetin (tslp) i postupci uporabe protutijela |
| EP4025602A4 (en) * | 2019-09-04 | 2023-12-13 | Biosion, Inc. | TSLP BINDING ANTIBODIES AND USES THEREOF |
| CN111171150B (zh) * | 2020-02-05 | 2020-12-08 | 北京智仁美博生物科技有限公司 | 抗人tslp抗体及其用途 |
-
2022
- 2022-12-23 JP JP2024538031A patent/JP2025500971A/ja active Pending
- 2022-12-23 US US18/722,607 patent/US20250051433A1/en active Pending
- 2022-12-23 AU AU2022423383A patent/AU2022423383A1/en active Pending
- 2022-12-23 TW TW111149729A patent/TW202337898A/zh unknown
- 2022-12-23 EP EP22910231.4A patent/EP4453030A1/en active Pending
- 2022-12-23 CN CN202280085371.7A patent/CN118475607A/zh active Pending
- 2022-12-23 MX MX2024007966A patent/MX2024007966A/es unknown
- 2022-12-23 WO PCT/CN2022/141670 patent/WO2023116925A1/en not_active Ceased
- 2022-12-23 CA CA3244178A patent/CA3244178A1/en active Pending
- 2022-12-23 IL IL313679A patent/IL313679A/en unknown
- 2022-12-23 KR KR1020247024935A patent/KR20240128709A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025500971A5 (https=) | ||
| JP2023075294A (ja) | 抗ｃｄ４７抗体及びその応用 | |
| AU2017328309B2 (en) | Antibody specifically binding to PD-1 and functional fragment thereof | |
| JP2019503687A (ja) | 抗ｐｄ−ｌ１抗体およびその使用 | |
| CN110066336B (zh) | 抗cd47单克隆抗体、片段及其医药用途 | |
| JP7728595B2 (ja) | 二重特異性抗体及びその用途 | |
| JP2021500856A (ja) | Ｉｌ−６ｒ抗体およびその抗原結合フラグメントならびに医薬としての使用 | |
| JP2024531462A (ja) | Ｆａｐ／ｃｄ４０結合分子及びその医薬的使用 | |
| KR102571012B1 (ko) | 항-il-22r 항체 | |
| WO2021013065A1 (zh) | 人源化抗VEGF Fab抗体片段及其用途 | |
| JP7352007B2 (ja) | ヒト化抗ｖｅｇｆモノクローナル抗体 | |
| KR20220079561A (ko) | 항-줄기세포 인자 항체 및 이의 사용 방법 | |
| JP2024511027A (ja) | 幹細胞因子抗体及びその使用方法 | |
| WO2019230869A1 (ja) | 抗ヒトｔｌｒ７抗体 | |
| CN120077072A (zh) | Cldn18.2/4-1bb结合蛋白及其医药用途 | |
| CA3019692A1 (en) | Monovalent inhibitor of hutnfr1 interaction | |
| CN112805297B (zh) | 抗人类pd-l1抗体及其用途 | |
| TW202525846A (zh) | 抗ｉｌ—１３多特異性抗體構築體及其用途 | |
| KR20220117307A (ko) | 인간 il-13 및 il-17에 대해 결합 특이성을 갖는 다중 특이적 항체 | |
| CN112480252A (zh) | 抗白细胞介素-33抗体及其制备方法和应用 | |
| JP2024543134A (ja) | 修飾されたタンパク質又はポリペプチド | |
| JP2019535236A (ja) | テネイシンエピトープと抗体 | |
| RU2024117489A (ru) | Новые антитела к TSLP | |
| RU2844744C1 (ru) | Антитела против фактора стволовых клеток и способы их применения | |
| CN116199777B (zh) | 抗hNKG2D抗体及其应用 |